Navigation Links
Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
Date:11/3/2008

p>

"Caring for the sick took priority over everything else in my husband's life," said Lily Safra. "During his lifetime he helped countless people receive medical treatment and was a generous supporter of scientific research around the world. It is therefore our privilege to be a partner in the Michael J. Fox Foundation's innovative, creative, and strategic efforts to find a cure for Parkinson's disease."

"The Michael J. Fox Foundation has been deeply fortunate to have the unflagging commitment of The Edmond J. Safra Foundation in our shared search for revolutionary treatments for Parkinson's disease," said Katie Hood, MJFF's chief executive officer.

The Edmond J. Safra Core Programs for PD Research, all of which fall at traditionally underfunded stages of the drug development pipeline, are:

Rapid Response Innovation Awards --- a one-of-a-kind, rolling-application program to support groundbreaking Parkinson's disease research in real-time. Rapid Response funds high-risk, high-reward projects within weeks of application, aiming to tackle critical scientific roadblocks and help open new avenues for PD therapy development.

Target Validation --- supports rigorous testing of early-stage discoveries to determine whether they are true targets for commercial therapeutic development. Target Validation projects are structured to conclusively confirm that a biological target plays a role in disease and that by modifying the target, symptoms or disease course can be altered.

Clinical Intervention Awards --- supports projects exploring new neuroprotective treatments, improvements on existing therapies, and development of treatments for unmet symptoms. The program funds proof-of-principle clinical research involving the active participation of small sample populations.

Other MJFF programs also have been made possible by the leadership generosity of The Edmond J. Safra Foundation. They include the 2007 funding round of MJFF's signature i
'/>"/>

SOURCE The Michael J. Fox Foundation for Parkinson?s Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
11. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 55929 1Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 55929 2Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 55929 3U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 1U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 2Empire Blue Cross Blue Shield Awarded NCQAs Accreditation Status of Excellent 55923 1Empire Blue Cross Blue Shield Awarded NCQAs Accreditation Status of Excellent 55923 2